1. Home
  2. LUNG vs LNZA Comparison

LUNG vs LNZA Comparison

Compare LUNG & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • LNZA
  • Stock Information
  • Founded
  • LUNG 1995
  • LNZA 2005
  • Country
  • LUNG United States
  • LNZA United States
  • Employees
  • LUNG N/A
  • LNZA N/A
  • Industry
  • LUNG Industrial Specialties
  • LNZA Major Chemicals
  • Sector
  • LUNG Health Care
  • LNZA Industrials
  • Exchange
  • LUNG Nasdaq
  • LNZA Nasdaq
  • Market Cap
  • LUNG 248.0M
  • LNZA 342.1M
  • IPO Year
  • LUNG 2020
  • LNZA N/A
  • Fundamental
  • Price
  • LUNG $7.31
  • LNZA $1.36
  • Analyst Decision
  • LUNG Strong Buy
  • LNZA Strong Buy
  • Analyst Count
  • LUNG 8
  • LNZA 4
  • Target Price
  • LUNG $14.88
  • LNZA $6.00
  • AVG Volume (30 Days)
  • LUNG 300.6K
  • LNZA 349.5K
  • Earning Date
  • LUNG 10-28-2024
  • LNZA 08-08-2024
  • Dividend Yield
  • LUNG N/A
  • LNZA N/A
  • EPS Growth
  • LUNG N/A
  • LNZA N/A
  • EPS
  • LUNG N/A
  • LNZA N/A
  • Revenue
  • LUNG $76,583,000.00
  • LNZA $67,687,000.00
  • Revenue This Year
  • LUNG $22.73
  • LNZA $44.54
  • Revenue Next Year
  • LUNG $19.02
  • LNZA $71.71
  • P/E Ratio
  • LUNG N/A
  • LNZA N/A
  • Revenue Growth
  • LUNG 26.26
  • LNZA 60.41
  • 52 Week Low
  • LUNG $5.46
  • LNZA $1.16
  • 52 Week High
  • LUNG $14.84
  • LNZA $8.70
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 55.79
  • LNZA 39.87
  • Support Level
  • LUNG $6.31
  • LNZA $1.44
  • Resistance Level
  • LUNG $7.68
  • LNZA $1.54
  • Average True Range (ATR)
  • LUNG 0.46
  • LNZA 0.14
  • MACD
  • LUNG 0.02
  • LNZA 0.00
  • Stochastic Oscillator
  • LUNG 61.73
  • LNZA 13.04

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About LNZA LanzaTech Global Inc.

LanzaTech Global Inc is a nature-based carbon refining company that transforms waste carbon into the chemical building blocks for consumer goods such as sustainable fuels, fabrics, and packaging that people use in their daily lives. The company's goal is to reduce the need for virgin fossil fuels by challenging and striving to change the way the world uses carbon.

Share on Social Networks: